Angiogenesis inhibitory agent
US5698586A · kind A · utility
77Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 1992 |
| Grant date | Dec 16, 1997 |
| Priority date | — |
| Expiry date | Jul 21, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
O-substituted fumagillol derivatives and its salts have an angiogenesis inhibiting activity and are useful for prophylaxis and treatment of diseases induced by abnormally stimulated neovascularization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.